Search

Record Type Journal Article Author/Creator Heng, D.Y.C.

2. Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database. Issue 1 (January 2020)

Authors:
Kushnir, I.; Kirk, L.; Mallick, R.; Kim, R.H.; Graham, G.E.; Breau, R.H.; Lattouf, J.-B.; Violette, P.D.; Pautler, S.E.; Care, M.; Kapoor, A.; Jewett, M.A.S.; Wood, L.; Tanguay, S.; Heng, D.Y.C.; Basappa, N.S.; So, A.; Pouliot, F.; Reaume, N.M.
Journal:
Clinical oncology
Issue:
Volume 32:Issue 1(2020)
Page Start:
e10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR). (February 2017)

Authors:
Schmidinger, M.; Motzer, R.J.; Powles, T.; Escudier, B.; Tannir, N.M.; Mainwaring, P.N.; Rini, B.I.; Hammers, H.J.; Donscov, F.; Roth, B.; Peltola, K.; Lee, J.L.; Heng, D.Y.C.; Aftab, D.T.; Hessel, C.; Scheffold, C.; Schwab, G.; Pal, S.; Hutson, T.E.; Choueiri, T.K.
Journal:
European journal of cancer
Issue:
Volume 72(2017)Supplement 1
Page Start:
S187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗